Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4588Pancreatic Neoplasms 2837Carcinoma, Hepatocellular 2473Stomach Neoplasms 2325Colonic Neoplasms 1790Rectal Neoplasms 1714Esophageal Neoplasms 1373Liver Neoplasms 920Neoplasms 913Breast Neoplasms 836Neoplasm Metastasis 761Carcinoma, Non-Small-Cell Lung 702Cholangiocarcinoma 581Lung Neoplasms 555Ovarian Neoplasms 533Esophageal Squamous Cell Carcinoma 510Gastrointestinal Neoplasms 494Melanoma 381Prostatic Neoplasms 371Biliary Tract Neoplasms 370Head and Neck Neoplasms 303Uterine Cervical Neoplasms 286Carcinoma, Renal Cell 282Adenocarcinoma Of Esophagus 273Sarcoma 263Squamous Cell Carcinoma of Head and Neck 262Gastrointestinal Stromal Tumors 251Endometrial Neoplasms 233Urinary Bladder Neoplasms 226Gallbladder Neoplasms 223

Interventions

Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Resectable Rectal Cancer × Gastrointestinal × Clear all
NCT07454720 2026-05-05

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 2/3 Recruiting
165 enrolled
Gastrointestinal

Locally Advanced Resectable Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡